Skip to main content

Research Repository

Advanced Search

Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation

Vara-Ciruelos, Diana; Dandapani, Madhumita; Russell, Fiona M.; Grzes, Katarzyna M.; Atrih, Abdelmadjid; Foretz, Marc; Viollet, Benoit; Lamont, Douglas J.; Cantrell, Doreen A.; Hardie, D. Grahame

Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation Thumbnail


Authors

Diana Vara-Ciruelos

Profile Image

Dr MADHUMITA DANDAPANI Madhumita.Dandapani@nottingham.ac.uk
Clinical Associate Professor of Paediatric Oncology/Neuro Oncology

Fiona M. Russell

Katarzyna M. Grzes

Abdelmadjid Atrih

Marc Foretz

Benoit Viollet

Douglas J. Lamont

Doreen A. Cantrell

D. Grahame Hardie



Abstract

AMPK acts downstream of the tumor suppressor LKB1, yet its role in cancer has been controversial. AMPK is activated by biguanides, such as metformin and phenformin, and metformin use in diabetics has
been associated with reduced cancer risk. However, whether this is mediated by cell-autonomous AMPK activation within tumor progenitor cells has been unclear. We report that T-cell-specific loss of AMPK-a1 caused accelerated growth of T cell acute lymphoblastic
leukemia/lymphoma (T-ALL) induced by PTEN loss in thymic T cell progenitors. Oral administration of phenformin, but not metformin, delayed onset and growth of lymphomas, but only when T cells expressed AMPK-a1. This differential effect of biguanides correlated with detection of phenformin, but not metformin, in thymus. Phenformin also enhanced apoptosis in T-ALL cells both in vivo and
in vitro. Thus, AMPK-a1 can be a cell-autonomous tumor suppressor in the context of T-ALL, and phenformin may have potential for the prevention of some cancers.

Citation

Vara-Ciruelos, D., Dandapani, M., Russell, F. M., Grzes, K. M., Atrih, A., Foretz, M., …Hardie, D. G. (2019). Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation. Cell Reports, 27(3), 690-698.e4. https://doi.org/10.1016/j.celrep.2019.03.067

Journal Article Type Article
Acceptance Date Mar 18, 2019
Online Publication Date Apr 16, 2019
Publication Date Apr 16, 2019
Deposit Date Nov 15, 2019
Publicly Available Date Nov 18, 2019
Journal Cell Reports
Print ISSN 2211-1247
Electronic ISSN 2211-1247
Publisher Cell Press
Peer Reviewed Peer Reviewed
Volume 27
Issue 3
Pages 690-698.e4
DOI https://doi.org/10.1016/j.celrep.2019.03.067
Keywords General Biochemistry, Genetics and Molecular Biology
Public URL https://nottingham-repository.worktribe.com/output/2142838
Publisher URL https://www.sciencedirect.com/science/article/pii/S2211124719303973?via%3Dihub

Files




You might also like



Downloadable Citations